NASDAQ:BLPH

Bellerophon Therapeutics SEC Filings & 10K Form

$4.08
+0.06 (+1.49 %)
(As of 06/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.94
$4.12
50-Day Range
$3.83
$4.74
52-Week Range
$3.79
$14.09
Volume56,173 shs
Average Volume69,562 shs
Market Capitalization$38.78 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.58

Bellerophon Therapeutics (NASDAQ:BLPH) SEC Filings

DateFilerForm TypeView
06/11/2021
7:36 AM
Bellerophon Therapeutics (Filer)
Form 8-K/A
06/11/2021
7:31 AM
Bellerophon Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/08/2021
11:37 AM
Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2021
3:05 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2021
7:36 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2021
7:30 AM
Bellerophon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/27/2021
8:45 PM
Bellerophon Therapeutics (Subject)
Puissance Life Science Opportunities Fund VI (Filed by)
Form SC 13D/A
04/26/2021
11:39 AM
Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2021
7:36 AM
Bellerophon Therapeutics (Filer)
Form DEFA14A
04/13/2021
7:31 AM
Bellerophon Therapeutics (Filer)
Form DEF 14A
04/02/2021
3:10 PM
Bellerophon Therapeutics (Issuer)
Peacock Jonathan M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
8:36 PM
Bellerophon Therapeutics (Issuer)
KLINSKY STEVEN B (Reporting)
New Mountain Capital, L.L.C. (Reporting)
New Mountain Investments II, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
7:35 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2021
7:31 AM
Bellerophon Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2021
4:27 PM
Bellerophon Therapeutics (Subject)
New Mountain Investments II, LLC (Filed by)
Form SC 13G/A
01/11/2021
7:01 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
12:52 PM
Bellerophon Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/01/2020
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/23/2020
7:33 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
7:30 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
7:29 AM
Bellerophon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/14/2020
3:04 PM
Bellerophon Therapeutics (Issuer)
FARES Wassim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
3:04 PM
Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
3:03 PM
Bellerophon Therapeutics (Issuer)
Teufel Crispin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
3:03 PM
Bellerophon Therapeutics (Issuer)
Moura Andre V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
3:03 PM
Bellerophon Therapeutics (Issuer)
BENNETT MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
3:02 PM
Bellerophon Therapeutics (Issuer)
Cloyd Mary Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
3:02 PM
Bellerophon Therapeutics (Issuer)
Bruder Scott P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
3:02 PM
Amin Naseem (Reporting)
Bellerophon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
7:31 AM
Bellerophon Therapeutics (Issuer)
FARES Wassim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
3:10 PM
Bellerophon Therapeutics (Issuer)
FARES Wassim (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2020
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2020
7:26 AM
Bellerophon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/13/2020
7:33 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2020
11:15 PM
Bellerophon Therapeutics (Filer)
Form EFFECT
06/26/2020
3:07 PM
Bellerophon Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/22/2020
6:38 AM
Bellerophon Therapeutics (Subject)
Puissance Life Science Opportunities Fund VI (Filed by)
Form SC 13D
05/22/2020
6:25 AM
Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:46 AM
Bellerophon Therapeutics (Subject)
Puissance Cross-Border Opportunities III LLC (Filed by)
Form SC 13D/A
05/11/2020
3:01 PM
Bellerophon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
7:29 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2020
3:31 PM
Bellerophon Therapeutics (Filer)
Form DEFA14A
04/23/2020
7:17 AM
Bellerophon Therapeutics (Filer)
Form DEF 14A
04/20/2020
9:47 AM
Bellerophon Therapeutics (Issuer)
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities III LLC (Reporting)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
7:32 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
7:27 AM
Bellerophon Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2020
12:28 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
6:03 AM
Bellerophon Therapeutics (Filer)
Form 424B5
03/30/2020
9:49 AM
Bellerophon Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
03/30/2020
7:01 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
7:33 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2020
7:33 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
7:32 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2020
9:00 AM
Bellerophon Therapeutics (Subject)
New Mountain Investments II, LLC (Filed by)
Form SC 13G/A
02/07/2020
11:05 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2020
3:24 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
3:51 PM
Bellerophon Therapeutics (Issuer)
Peacock Jonathan M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:22 AM
Bellerophon Therapeutics (Filer)
Form DEF 14A
12/27/2019
7:25 AM
Bellerophon Therapeutics (Filer)
Form PRE 14A
12/17/2019
7:24 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
3:52 PM
Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:36 PM
Bellerophon Therapeutics (Issuer)
Shah Parag Suresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:36 PM
Bellerophon Therapeutics (Issuer)
Fernandes Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:36 PM
Bellerophon Therapeutics (Issuer)
Tenenbaum Fabian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:35 PM
Bellerophon Therapeutics (Issuer)
Dekker Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:35 PM
Bellerophon Therapeutics (Issuer)
Korner Assaf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
7:30 AM
Bellerophon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2019
4:17 PM
Bellerophon Therapeutics (Issuer)
Shah Nimish P (Reporting)
VENROCK ASSOCIATES IV L P (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:15 PM
Bellerophon Therapeutics (Issuer)
Koh Bong Y (Reporting)
VEF Management IV, LLC (Reporting)
VENROCK ASSOCIATES IV L P (Reporting)
VENROCK ENTREPRENEURS FUND IV L P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Management IV, LLC (Reporting)
Venrock Partners Management, LLC (Reporting)
Venrock Partners, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Management II, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
3:54 PM
Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:54 PM
Bellerophon Therapeutics (Issuer)
Teufel Crispin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:53 PM
Bellerophon Therapeutics (Issuer)
Shah Parag Suresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:53 PM
Bellerophon Therapeutics (Issuer)
Moura Andre V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:53 PM
Bellerophon Therapeutics (Issuer)
Fernandes Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:52 PM
Bellerophon Therapeutics (Issuer)
Tenenbaum Fabian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:52 PM
Bellerophon Therapeutics (Issuer)
Dekker Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:51 PM
Bellerophon Therapeutics (Issuer)
Cloyd Mary Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:51 PM
Bellerophon Therapeutics (Issuer)
Bruder Scott P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:50 PM
Bellerophon Therapeutics (Issuer)
Korner Assaf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:50 PM
Amin Naseem (Reporting)
Bellerophon Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:48 PM
Bellerophon Therapeutics (Issuer)
BENNETT MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
3:39 PM
Bellerophon Therapeutics (Issuer)
Edmonds Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
7:31 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
12:08 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
7:32 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
7:31 AM
Bellerophon Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
7:35 AM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
3:31 PM
Bellerophon Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
10:46 AM
Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:46 PM
Bellerophon Therapeutics (Issuer)
Teufel Crispin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:24 AM
Bellerophon Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/24/2019
8:30 AM
Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
3:46 PM
Bellerophon Therapeutics (Issuer)
Edmonds Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
10:15 AM
Bellerophon Therapeutics (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
10:14 AM
Bellerophon Therapeutics (Issuer)
Peacock Jonathan M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.